Suicide Prevention by Lithium (SUPLI) - Challenges of a multi-center prospective study

Erik Lauterbach*, Bernd Ahrens, Werner Felber, Bruno Muller-Oerlinghausen, Birgit Kilb, Gerd Bischof, Isabella Heuser, Petra Werner, Barbara Hawellek, Wolfgang Maier, Ute Lewitzka, Oliver Pogarell, Ulrich Hegerl, Thomas Bronisch, Kneginja Richter, Günther Niklewski, Andreas Broocks, Fritz Hohagen

*Korrespondierende/r Autor/-in für diese Arbeit
15 Zitate (Scopus)

Abstract

Several studies have shown that there is a significantly increased risk of suicide related mortality in patients with a positive history of suicide attempts. The SUPLI-Study is the first prospective, randomized, double blind, placebo controlled multi-center trial focusing on the proposed suicide preventive effects of lithium in patients with suicidal behavior but not suffering from bipolar disorder or recurrent major depressive disorder. Patients with a recent history of a suicide attempt are treated with lithium versus placebo during a 12 month period. The hypothesis is that lithium treatment will lead to a 50% reduction of suicidal behavior. The protocol of the study and preliminary results an presented.

OriginalspracheEnglisch
ZeitschriftArchives of Suicide Research
Jahrgang9
Ausgabenummer1
Seiten (von - bis)27-34
Seitenumfang8
ISSN1381-1118
DOIs
PublikationsstatusVeröffentlicht - 2005

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Suicide Prevention by Lithium (SUPLI) - Challenges of a multi-center prospective study“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren